Home
About us
What We Do
Vision
Focus Area
Collaborations
Funding
Output
People
Anneke Hesseling
Annelies Van Rie
Anzaan Dippenaar
Bart Cuypers
Brendon Mann
Conor Meehan
Elise De Vos
Emilyn C Conceicao
Emmanuel Rivière
Eskedar Mekonnen
Felicia Wells
Gerard Tromp
Grant Theron
Herman Goossens
Johannes Loubser
Justice T N Ngom
Kris Laukens
Lena Krauẞer
Lennert Verboven
Lizma Streicher
Margaretha de Vos
Marisa Klopper
Melanie Grobbelaar
Michael Whitfield
Miguel de D Fuertes
Miriam Ngarega
Nabila Ismail
Nandi Niemand
Rob Warren
Sander Goossens
Selien Oostvogels
Serej Ley
Shata Omar
Taime Sylvester
Tim Heupink
Vincent Rennie
Zhiheng Wang
Projects
VLIR-UOS
EXIT-RIF
SMARTT trial
MICK-MAGMA Platform
GenPath Africa - PARR-TB
PARR-TB Study
Introduction
Informed Consent
Account Setup
MICK-MAGMA Tutorial
Troubleshooting
CRO Details
FAQs
Contact Form
Supporting Documents
Vacancies
PhD
Post doc
Other
News
Publications
Contact us
TORCH
Home
About us
What We Do
Vision
Focus Area
Collaborations
Funding
Output
People
Anneke Hesseling
Annelies Van Rie
Anzaan Dippenaar
Bart Cuypers
Brendon Mann
Conor Meehan
Elise De Vos
Emilyn C Conceicao
Emmanuel Rivière
Eskedar Mekonnen
Felicia Wells
Gerard Tromp
Grant Theron
Herman Goossens
Johannes Loubser
Justice T N Ngom
Kris Laukens
Lena Krauẞer
Lennert Verboven
Lizma Streicher
Margaretha de Vos
Marisa Klopper
Melanie Grobbelaar
Michael Whitfield
Miguel de D Fuertes
Miriam Ngarega
Nabila Ismail
Nandi Niemand
Rob Warren
Sander Goossens
Selien Oostvogels
Serej Ley
Shata Omar
Taime Sylvester
Tim Heupink
Vincent Rennie
Zhiheng Wang
Projects
VLIR-UOS
EXIT-RIF
SMARTT trial
MICK-MAGMA Platform
GenPath Africa - PARR-TB
PARR-TB Study
Introduction
Informed Consent
Account Setup
MICK-MAGMA Tutorial
Troubleshooting
CRO Details
FAQs
Contact Form
Supporting Documents
Vacancies
PhD
Post doc
Other
News
Publications
Contact us
PARR-TB Study
Introduction
Informed Consent
Account Setup
MICK-MAGMA Tutorial
Troubleshooting
CRO Details
FAQs
Contact Form
Supporting Documents
Please find below a tutorial on using MICK-MAGMA as a DR-TB treatment decision aid:
